Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects:

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. by Bethel Alebel Bayrau (22676588)

Subjects:

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects:

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects:

Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. by Bethel Alebel Bayrau (22676588)

Subjects: